Patient-Reported Symptom Severity Among 22,650 Cancer Outpatients in the Last Six Months of Life.


Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
01 2020
Historique:
received: 27 06 2019
revised: 09 08 2019
accepted: 09 08 2019
pubmed: 21 8 2019
medline: 8 1 2021
entrez: 21 8 2019
Statut: ppublish

Résumé

Understanding the magnitude and risk factors for symptom burden of patients with cancer at the end of life is critical to guiding effective patient- and system-level interventions. We aimed to estimate the prevalence of severe patient-reported symptoms among cancer outpatients during the six months before death and to identify patient groups at a higher risk for reporting severe symptoms. This was a retrospective cohort study of cancer decedents at regional cancer centers from 2010 to 2016. Patient-reported Edmonton Symptom Assessment System (ESAS) scores from the last six months of life were linked to administrative databases. The proportion of patients reporting severe symptom scores (≥7) for anxiety, depression, drowsiness, lack of appetite, nausea, pain, shortness of breath, tiredness, and overall well-being during the six months before death was described. Multivariable modified Poisson regression analyses were used to identify risk factors for reporting severe symptom scores. Of 39,084 cancer decedents, 22,650 had one or more symptom assessments recorded in the last six months of life, resulting in 92,757 ESAS assessments. Severe scores were highest for tiredness (56%), lack of appetite (46%), and impaired well-being (45%). The proportion of patients reporting severe symptom scores was stable before progressively increasing at three months before death. Elderly, women, patients with high comorbidity, immigrants, and living in urban areas or with high material deprivation were at increased risk of reporting severe scores. Despite an integrated symptom screening program, rates of severe patient-reported symptom scores before death were high for outpatients with cancer. Patient subgroups at increased risk of severe symptom burden may benefit from targeted interventions. Ongoing review of routinely collected symptom data may be used to assess the supportive care needs and guide targeted interventions at the health-system level.

Identifiants

pubmed: 31430522
pii: S0885-3924(19)30462-2
doi: 10.1016/j.jpainsymman.2019.08.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-66.e4

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Lev D Bubis (LD)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada.

Laura E Davis (LE)

Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.

Hera Canaj (H)

Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.

Vaibhav Gupta (V)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada.

Yunni Jeong (Y)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada.

Lisa Barbera (L)

Division of Radiation Oncology, University of Calgary, Calgary, Canada.

Qing Li (Q)

Institute for Clinical Evaluative Sciences, Toronto, Canada.

Lesley Moody (L)

Cancer Care Ontario, Toronto, Canada.

Paul J Karanicolas (PJ)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Canada.

Rinku Sutradhar (R)

Institute for Clinical Evaluative Sciences, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Department of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Natalie G Coburn (NG)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Canada. Electronic address: laura.davis4@mcgill.ca.

Alyson L Mahar (AL)

Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH